Congratulations to Elizabeth Robinson, MD, PGY-III, in the Department of Dermatology at the George Washington University School of Medicine and Health Sciences, on receiving two research awards.
The DermMentors Resident of Distinction Award and the Rising Derm Stars Award both acknowledged Robinson’s research on the use of a synthetic anti-inflammatory cannabinoid as a dermatological treatment. Robinson looked at ajulemic acid in particular, which is a result of modifications to the THC compound found in cannabis. Her research shows that this modification and others display anti-inflammatory properties without causing central nervous system activity.
“Winning these distinctions confirms the potential impact of this research,” Robinson said. “This study shows the opportunities for new and improved therapeutics in dermatology.”
Robinson received the DermMentors Resident of Distinction Award, sponsored by Beiersdorf, a German personal care company, at the Coastal Dermatology Symposium. As one of five recipients, Robinson was invited to present her research at the conference, held Oct. 5–7 in Portland, Oregon. Award recipients also were assigned mentors and had the opportunity to learn from and interact with top thought leaders in dermatology.
As a recipient of the Rising Derm Stars Award, Robinson presented her research at the Fall Clinical Dermatology Conference held in Las Vegas in October 2017. Residents are paired with mentors for the duration of the conference, enhancing the overall experience.
“It’s a real honor to present and be recognized at these conferences,” said Robinson. “This research has gotten great attention from my peers in dermatology for the contribution that it can make in the field.”
